SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006147
Filing Date
2017-08-07
Accepted
2017-08-07 17:20:00
Documents
49
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20170630x10q.htm 10-Q 1660725
2 EX-31.1 xncr-20170630ex3115c26f2.htm EX-31.1 19325
3 EX-31.2 xncr-20170630ex3129aa9d5.htm EX-31.2 19345
4 EX-32.1 xncr-20170630ex321c5a5be.htm EX-32.1 10451
  Complete submission text file 0001558370-17-006147.txt   6145125

Data Files

Seq Description Document Type Size
5 EX-101.INS xncr-20170630.xml EX-101.INS 1421740
6 EX-101.SCH xncr-20170630.xsd EX-101.SCH 32441
7 EX-101.CAL xncr-20170630_cal.xml EX-101.CAL 41854
8 EX-101.DEF xncr-20170630_def.xml EX-101.DEF 125897
9 EX-101.LAB xncr-20170630_lab.xml EX-101.LAB 371700
10 EX-101.PRE xncr-20170630_pre.xml EX-101.PRE 250801
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 171012616
SIC: 2834 Pharmaceutical Preparations